Cargando…

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()

INTRODUCTION: The post-COVID condition has become a social concern. Although the patient characteristics associated with the development of this condition are partially known, those associated with its persistence have not been identified. METHODS: We conducted a cross-sectional questionnaire-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazato, Yusuke, Tsuzuki, Shinya, Morioka, Shinichiro, Terada, Mari, Kutsuna, Satoshi, Saito, Sho, Shimanishi, Yumiko, Takahashi, Kozue, Sanada, Mio, Akashi, Masako, Kuge, Chika, Osanai, Yasuyo, Tanaka, Keiko, Suzuki, Michiyo, Hayakawa, Kayoko, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114006/
https://www.ncbi.nlm.nih.gov/pubmed/35595598
http://dx.doi.org/10.1016/j.jiac.2022.04.025
_version_ 1784709689563414528
author Miyazato, Yusuke
Tsuzuki, Shinya
Morioka, Shinichiro
Terada, Mari
Kutsuna, Satoshi
Saito, Sho
Shimanishi, Yumiko
Takahashi, Kozue
Sanada, Mio
Akashi, Masako
Kuge, Chika
Osanai, Yasuyo
Tanaka, Keiko
Suzuki, Michiyo
Hayakawa, Kayoko
Ohmagari, Norio
author_facet Miyazato, Yusuke
Tsuzuki, Shinya
Morioka, Shinichiro
Terada, Mari
Kutsuna, Satoshi
Saito, Sho
Shimanishi, Yumiko
Takahashi, Kozue
Sanada, Mio
Akashi, Masako
Kuge, Chika
Osanai, Yasuyo
Tanaka, Keiko
Suzuki, Michiyo
Hayakawa, Kayoko
Ohmagari, Norio
author_sort Miyazato, Yusuke
collection PubMed
description INTRODUCTION: The post-COVID condition has become a social concern. Although the patient characteristics associated with the development of this condition are partially known, those associated with its persistence have not been identified. METHODS: We conducted a cross-sectional questionnaire-based survey among patients who had recovered from COVID-19 and visited the National Center for Global Health and Medicine between February 2021 and March 2021. Demographic and clinical data, and data regarding the presence and duration of post-COVID conditions were obtained. We identified factors associated with the development and persistence of post-COVID conditions using multivariate logistic and linear regression analyses, respectively. RESULTS: We analyzed 457 of 526 responses (response rate, 86.9%). The median patient age was 47 years. Of these, 378 patients (84.4%) had mild disease in the acute phase. The number of patients with symptoms at 6 and 12 months after onset or diagnosis was 120 (26.3%) and 40 (8.8%), respectively. Women were at risk of developing fatigue (odds ratio [OR]: 2.03, 95% confidence interval [CI]: 1.31–3.14), dysosmia (OR: 1.91, 95%CI: 1.24–2.93), dysgeusia (OR: 1.56, 95%CI: 1.02–2.39), hair loss (OR: 3.00, 95%CI: 1.77–5.09), and persistence of any symptoms (coefficient: 38.0, 95%CI: 13.3–62.8). Younger age and low body mass index were factors for developing dysosmia (OR: 0.96, 95%CI: 0.94–0.98 and OR: 0.94, 95%CI: 0.89–0.99, respectively) and dysgeusia (OR: 0.98, 95%CI: 0.96–1.00 and OR: 0.93, 95%CI: 0.88–0.98, respectively). CONCLUSION: We identified factors involved in the development and persistence of post-COVID conditions. Many patients, even those with mild conditions, experience long-term residual symptoms.
format Online
Article
Text
id pubmed-9114006
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-91140062022-05-18 Factors associated with development and persistence of post-COVID conditions: A cross-sectional study() Miyazato, Yusuke Tsuzuki, Shinya Morioka, Shinichiro Terada, Mari Kutsuna, Satoshi Saito, Sho Shimanishi, Yumiko Takahashi, Kozue Sanada, Mio Akashi, Masako Kuge, Chika Osanai, Yasuyo Tanaka, Keiko Suzuki, Michiyo Hayakawa, Kayoko Ohmagari, Norio J Infect Chemother Original Article INTRODUCTION: The post-COVID condition has become a social concern. Although the patient characteristics associated with the development of this condition are partially known, those associated with its persistence have not been identified. METHODS: We conducted a cross-sectional questionnaire-based survey among patients who had recovered from COVID-19 and visited the National Center for Global Health and Medicine between February 2021 and March 2021. Demographic and clinical data, and data regarding the presence and duration of post-COVID conditions were obtained. We identified factors associated with the development and persistence of post-COVID conditions using multivariate logistic and linear regression analyses, respectively. RESULTS: We analyzed 457 of 526 responses (response rate, 86.9%). The median patient age was 47 years. Of these, 378 patients (84.4%) had mild disease in the acute phase. The number of patients with symptoms at 6 and 12 months after onset or diagnosis was 120 (26.3%) and 40 (8.8%), respectively. Women were at risk of developing fatigue (odds ratio [OR]: 2.03, 95% confidence interval [CI]: 1.31–3.14), dysosmia (OR: 1.91, 95%CI: 1.24–2.93), dysgeusia (OR: 1.56, 95%CI: 1.02–2.39), hair loss (OR: 3.00, 95%CI: 1.77–5.09), and persistence of any symptoms (coefficient: 38.0, 95%CI: 13.3–62.8). Younger age and low body mass index were factors for developing dysosmia (OR: 0.96, 95%CI: 0.94–0.98 and OR: 0.94, 95%CI: 0.89–0.99, respectively) and dysgeusia (OR: 0.98, 95%CI: 0.96–1.00 and OR: 0.93, 95%CI: 0.88–0.98, respectively). CONCLUSION: We identified factors involved in the development and persistence of post-COVID conditions. Many patients, even those with mild conditions, experience long-term residual symptoms. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022-09 2022-05-18 /pmc/articles/PMC9114006/ /pubmed/35595598 http://dx.doi.org/10.1016/j.jiac.2022.04.025 Text en © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Miyazato, Yusuke
Tsuzuki, Shinya
Morioka, Shinichiro
Terada, Mari
Kutsuna, Satoshi
Saito, Sho
Shimanishi, Yumiko
Takahashi, Kozue
Sanada, Mio
Akashi, Masako
Kuge, Chika
Osanai, Yasuyo
Tanaka, Keiko
Suzuki, Michiyo
Hayakawa, Kayoko
Ohmagari, Norio
Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
title Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
title_full Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
title_fullStr Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
title_full_unstemmed Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
title_short Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
title_sort factors associated with development and persistence of post-covid conditions: a cross-sectional study()
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114006/
https://www.ncbi.nlm.nih.gov/pubmed/35595598
http://dx.doi.org/10.1016/j.jiac.2022.04.025
work_keys_str_mv AT miyazatoyusuke factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT tsuzukishinya factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT moriokashinichiro factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT teradamari factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT kutsunasatoshi factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT saitosho factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT shimanishiyumiko factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT takahashikozue factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT sanadamio factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT akashimasako factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT kugechika factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT osanaiyasuyo factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT tanakakeiko factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT suzukimichiyo factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT hayakawakayoko factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy
AT ohmagarinorio factorsassociatedwithdevelopmentandpersistenceofpostcovidconditionsacrosssectionalstudy